Sotera Health Company (SHC) fair value analysis

Nasdaq · Updated 2026-09-07

Sotera Health Company is a provider of sterilization, cleaning, and contamination control solutions for the medical device and pharmaceutical industries. The company operates globally, serving customers across North America, Europe, and other international markets through its network of facilities and service centers.

Forward Fair Value verdict

Fairly valued

Based on TickrTrends' weekly Forward Fair Value model, SHC is trading at within about 10% of estimated fair value.

SHC currently ranks #67 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Fairly valued for 3 consecutive weekly runs.

Last price: $17.99
Sector: Healthcare
12-month range: $14.87–$18.30

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: C
Leverage: High
Margin trend: Stable
Revenue growth: Modest
RSI zone: Neutral
50/200-day trend: Mixed
52-week position: The top quarter of its range

What our data shows for SHC

Our model validated 17 trailing price-to-earnings windows for SHC, built from quarterly earnings records.
Shares are trading in the upper third of their 12-month price range of $14.87–$18.30.
The 14-day relative strength index sits at a neutral 56.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for SHC
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent SHC news

TickrTrends' derived news-sentiment signal for SHC is currently leaning positive, computed from recent coverage.

Sotera Health Company (SHC) Reported Positive Results Amid Litigation Wins (insidermonkey.com, 2026-08-10)
TickrTrends take: Sotera Health Company operates in the Healthcare sector and is currently assessed as fairly valued according to TickrTrends metrics. The company's positive results and litigation wins provide operational momentum that valuation-focused investors should monitor to determine whether these developments support the fair value assessment or signal a need for valuation adjustment. As litigation risks resolve favorably, tracking whether improved financial performance translates into sustained earnings growth will be important for validating the current valuation stance.
Sotera Health Company (SHC) Reported Positive Results Amid Litigation Wins (finance.yahoo.com, 2026-08-10)
TickrTrends take: Sotera Health Company operates in the Healthcare sector and is currently assessed as Fairly valued according to TickrTrends analysis. The company's litigation wins and positive operational results represent developments that valuation-focused investors should monitor to determine whether these favorable outcomes support or challenge the current fair value assessment. Continued tracking of how these wins translate into financial performance will be relevant for evaluating whether the fair value designation remains appropriate.
Sotera Health Company (SHC) Beats Q2 Earnings and Revenue Estimates (zacks.com, 2026-08-06)
TickrTrends take: Sotera Health Company's better-than-expected Q2 performance occurs within a valuation context where TickrTrends currently assesses the stock as fairly valued. For investors focused on valuation metrics, the relevance of earnings beats depends on whether the company can sustain this operational performance and translate it into margin expansion or growth acceleration that might shift the valuation assessment. As a healthcare sector participant, SHC's ability to maintain beat rates across future quarters will be a key metric to monitor against its current fair value positioning.

What people are saying

Follow the SHC conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — No material change this week: the verdict, bands and grades all held steady.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is SHC stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), SHC is trading at within about 10% of estimated fair value and screens as fairly valued. The exact fair value and discount are available to subscribers.

What is SHC's TickrTrends verdict?

SHC's current verdict is Fairly valued, refreshed with every weekly Forward Fair Value run.

How does SHC compare to other Healthcare stocks?

SHC ranks #67 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is SHC overbought or oversold?

SHC's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Healthcare fair-value coverage →

Head-to-head comparisons

SHC vs AZTA · SHC vs BAX · SHC vs DHR · SHC vs HSIC · SHC vs IQV